WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012041311) PERMANENT HUMAN AMNIOCYTE CELL LINES FOR PRODUCING INFLUENZA VIRUSES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/041311    International Application No.:    PCT/DE2011/075194
Publication Date: 05.04.2012 International Filing Date: 16.08.2011
Chapter 2 Demand Filed:    18.06.2012    
IPC:
C12N 7/02 (2006.01), C07K 14/11 (2006.01)
Applicants: CEVEC PHARMACEUTICALS GMBH [DE/DE]; Gottfried-Hagen-Str. 62 51105 Köln (DE) (For All Designated States Except US).
SCHIEDNER, Gudrun [DE/DE]; (DE) (For US Only)
Inventors: SCHIEDNER, Gudrun; (DE)
Agent: BETTENHAUSEN, Berthold; Dehmel und Bettenhausen Patent- & Rechtsanwälte Herzogspitalstraße 11 80331 München (DE)
Priority Data:
10 2010 037 008.8 16.08.2010 DE
10 2011 050 353.6 13.05.2011 DE
Title (DE) PERMANENTE HUMANE AMNIOZYTEN ZELLLINIE ZUR HERSTELLUNG VON INFLUENZAVIREN
(EN) PERMANENT HUMAN AMNIOCYTE CELL LINES FOR PRODUCING INFLUENZA VIRUSES
(FR) LIGNÉES CELLULAIRES AMNIOTIQUES HUMAINES PERMANENTES UTILISÉES POUR PRODUIRE DES VIRUS DE LA GRIPPE
Abstract: front page image
(DE)Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung eines Influenzavirus- basierten Impfstoffs mittels permanenten humanen Amniozytenzellen, sowie die Verwendung einer permanenten humanen Amniozytenzelle zur Herstellung eines Influenzavirus-basierten Impfstoffs.
(EN)The invention relates to a method for producing an influenza virus-based vaccine by means of permanent human amniocyte cells, and to the use of a permanent human amniocyte cells for producing an influenza virus-based vaccine.
(FR)La présente invention concerne un procédé de production d'un vaccin à base de virus de la grippe au moyen de cellules amniotiques humaines permanentes, ainsi que l'utilisation d'une cellule amniotique humaine permanente pour la production d'un vaccin à base de virus de la grippe.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: German (DE)
Filing Language: German (DE)